SEC 13F Intelligence

Birch Hill Investment Advisors LLC / VRTX

Birch Hill Investment Advisors LLC’s Vertex Pharmaceuticals Inc Position

Does Birch Hill Investment Advisors LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes150.8K shares worth $67M (+3.02% of its 13F portfolio) as of Q1 2026, down from 152.5K shares the prior filed quarter.

Position Value
$67M
Q1 2026
Shares
150.8K
% of Portfolio
+3.02%
Quarters Held
21
currently held

Position History VRTX

Reported value by quarter
Q1 ’21: $34MQ1 ’21Q2 ’21: $39MQ3 ’21: $36MQ4 ’21: $54MQ4 ’21Q1 ’22: $61MQ2 ’22: $61MQ3 ’22: $61MQ3 ’22Q4 ’22: $59MQ1 ’23: $60MQ2 ’23: $66MQ2 ’23Q3 ’23: $65MQ4 ’23: $76MQ1 ’24: $72MQ1 ’24Q2 ’24: $80MQ3 ’24: $78MQ4 ’24: $70MQ4 ’24Q1 ’25: $72MQ2 ’25: $66MQ3 ’25: $60MQ3 ’25Q4 ’25: $69MQ1 ’26: $67Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026150.8K$67M+3.02%
Q4 2025152.5K$69M+2.89%
Q3 2025153.6K$60M+2.54%
Q2 2025148.3K$66M+2.93%
Q1 2025148.3K$72M+3.41%
Q4 2024172.8K$70M+3.24%
Q3 2024168.2K$78M+3.67%
Q2 2024171.5K$80M+3.89%
Q1 2024171.7K$72M+3.49%
Q4 2023187.3K$76M+4.06%
Q3 2023185.7K$65M+3.85%
Q2 2023186.6K$66M+3.77%
Q1 2023191.4K$60M+3.75%
Q4 2022204.3K$59M+3.76%
Q3 2022210.5K$61M+4.12%
Q2 2022217.2K$61M+3.82%
Q1 2022234.1K$61M+3.26%
Q4 2021247.2K$54M+2.69%
Q3 2021197.1K$36M+1.92%
Q2 2021195.6K$39M+2.12%
Q1 2021156.2K$34M+1.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birch Hill Investment Advisors LLC’s full portfolio or all institutional holders of VRTX.